澳门大阳城122.ccapp官方下载

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.

Mol. Cancer. 2017; 
YuMingjun,XueYixue,ZhengJian,LiuXiaobai,YuHai,LiuLibo,LiZhen,LiuYu
Products/Services Used Details Operation
Plasmid DNA Preparation Short-hairpin RNA directed against human linc00152 plasmid (sh-linc00152), short-hairpin RNA directed against human FEZF1 plasmid (FEZF1(−)), short-hairpin RNA Yu et al. Molecular Cancer (2017) 16:110 Page 14 of 18directed against human CDC25A plasmid (CDC25A(−)) and their respective non-targeting sequence (negative control, NC) were synthesized (GenePharma, Shanghai, China). FEZF1 full length (FEZF1(+)) plasmid, CDC25A full length (CDC25A(+)) plasmid, and their respective non-targeting sequence (negative control, NC) were synthesized (GenScript, Piscataway, NJ, USA). Get A Quote

摘要

Glioma is one of the most frequent intracranial malignant tumors. LncRNAs have been identified as new modulators in the origination and progression of glioma.

关键词

CDC25A,FEZF1,Glioma stem cells,Long non-coding RNA,linc00152,miR-103